• Human Longevity Acquires Cypher Genomics, Genomics Interpretation Software

    Nov 30, 2015, 15:45 PM by Michael Croft
    Bio-IT World | Human Longevity this morning announced that it has acquired Cypher Genomics for an undisclosed amount. Cypher has 14 employees who will join HLI including Cypher CEO and Co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI's Pediatric Business.
    Full story
  • Microbiome Startup uBiome Will Sequence Poop for the CDC

    Nov 30, 2015, 15:34 PM by Michael Croft
    Wired | uBiome has announced a partnership with the Centers for Disease Control and Prevention to develop a standardized way of measuring disruptions and changes to the human microbiome.
    Full story
  • Systematic CRISPR Knockouts in Cancer Cell Lines

    Nov 30, 2015, 10:58 AM by Michael Croft
    The Atlantic | CRISPR-Cas9 experiments are revealing which human genes are essential, and which matter specifically to cancer cells.
    Full story
  • Engineering a Promising Drug Candidate for Alzheimer's Disease

    Nov 30, 2015, 03:31 AM by Michael Croft
    ULSAN, SOUTH KOREA - Nov 24, 2015 - Alzheimer's disease (AD) is one of the most well-known and common form of dementia. It is also a progressive, degenerative brain disease whose cause is not fully understood, however, amyloid-β (Aβ) peptides, metal ions and reactive oxygen species (ROS) have been suggested to be involved in AD pathogenesis
    Full story
  • sciNote - First Open Source Scientific Notebook Released On Kickstarter

    Nov 26, 2015, 09:30 AM by Michael Croft
    BOSTON, MA - Nov 26, 2015 - The creators behind sciNote - an open source electronic laboratory notebook (ELN) - believe that laboratories deserve reliable and easy-to-use software at affordable prices
    Full story
  • Quanterix Upgrades Simoa Instruments, Preparing for 2016 IPO

    Nov 25, 2015, 11:40 AM by Michael Croft
    Diagnostics World | Quanterix, the Lexington, Mass.-based creator of a high-throughput protein analysis instrument, is overhauling its hardware and software as it prepares for a more commercial stage in its development.
    Full story
  • Complete Genomics Loses Staff, Delays Revolocity as BGI Seeks Support for BGISEQ-500

    Nov 24, 2015, 10:40 AM by Michael Croft
    Bio-IT World News Brief | Complete Genomics of Mountain View, Calif., is undergoing a big shakeup under the direction of its Shenzhen-based owner BGI, reorganizing as a research site developing assays for the BGISEQ-500 and cutting short the launch of its Revolocity clinical sequencing system.
    Full story
  • Genome Korea in Ulsan Launched

    Nov 24, 2015, 08:21 AM by Michael Croft
    ULSAN, KOREA - Nov 25, 2015 -  The Ulsan 10,000 Genome Project, entitled the "Genome Korea in Ulsan" has been launched in Ulsan Metropolitan City on the 25th of Nov
    Full story
  • Mosquito Gene Drive Appears Successful in the Lab

    Nov 23, 2015, 15:53 PM by Michael Croft
    STAT | Scientists have used the CRISPR-Cas9 genome-editing tool to create mosquitoes that block the malaria parasite instead of transmitting it - and rapidly spread their modified DNA to nearly all their descendants.
    Full story
  • Thermo Fisher Prepares for NGS Cancer Testing with Pharma Partners

    Nov 20, 2015, 13:15 PM by Michael Croft
    Bio-IT World | Thermo Fisher Scientific announced this week that it will be creating a next-generation sequencing test as a companion diagnostic in cases of non-small cell lung cancer, partnering with Novartis and Pfizer.
    Full story
  • Genedata Announces AstraZeneca Standardizes on Genedata Screener as its Global Screening Platform

    Nov 20, 2015, 09:24 AM by Michael Croft
    BASEL, N/A, SWITZERLAND - Nov 20, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced it has signed a five-year license agreement with AstraZeneca
    Full story
  • Oxford Nanopore's Software Side

    Nov 19, 2015, 10:55 AM by Michael Croft
    Bio-IT World | Oxford Nanopore, creator of the handheld MinION DNA sequencer, recently revealed its first user-facing tool for genetic interpretation, a species identification workflow called What's in my Pot? The tool, designed by Oxford's software spinout Metrichor, hints at the company's ambitions to bring DNA analysis to a much wider audience, as the MinION broadens notions of who can perform sequencing and where.
    Full story
  • How Genetics Defines, and Redefines, Biological Sex

    Nov 19, 2015, 09:17 AM by Michael Croft
    Nature News | The idea of two sexes, divided neatly by X and Y chromosomes, is simplistic. Biologists are now finding a fascinating number and variety of ways genetics can defy the binary.
    Full story
  • JUNIPER PHARMA SERVICES STRENGTHENS CAPSULE CAPABILITY WITH XCELODOSE

    Nov 19, 2015, 05:39 AM by Michael Croft
    NOTTINGHAM, UNITED KINGDOM - Nov 19, 2015 - Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage capsule filling expertise with the expansion of its Xcelodose® powder micro-dosing system as part of its suite of GMP capabiliThe move by the contract development and manufacturing organisation (CDMO) follows demand from its clients to develop the technique to complement its development services and help get new molecules to Phase I clinical trials quicker
    Full story
  • COGSTATE IPAD COGNITIVE ASSESSMENTS SELECTED FOR USE IN PHASE IV OBSERVATIONAL STUDY OF APPROVED TREATMENTS FOR PROSTATE CANCER

    Nov 18, 2015, 11:39 AM by Michael Croft
    - Nov 18, 2015 - Cogstate Ltd (ASX: CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment technology has been selected for use in a multicenter Phase IV observational study to assess the tolerability of two approved drugs for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    Full story
  • Deep Genomics Closes Seed Round of $3.7m

    Nov 18, 2015, 10:05 AM by Michael Croft
    Bio-IT World | Deep Genomics this morning announced the closing of $3.7 million in seed financing. Funding was led by True Ventures of the Bay Area with participation from Bloomberg Beta and other global angel investors.
    Full story
  • Former Biogen R&D Chief Emerges at $80M Startup Pursuing Cancer Alzheimers

    Nov 17, 2015, 09:50 AM by Michael Croft
    Forbes | Doug Williams left one of biotechnology's biggest jobs, at Biogen, in July. Now we know why. Williams is now the founding CEO of Codiak Biosciences, a Cambridge, Mass.-based startup. The little company is announcing today it has raised $80 million in committed venture capital spread over two installments.
    Full story
  • BC Platforms Appoints Mark Daly as Chairman of its Scientific Advisory Board and Expands Senior Management Team in the US

    Nov 16, 2015, 15:16 PM by Michael Croft
    HELSINKI, FINLAND - Nov 16, 2015 - BC Platforms today announced that it has appointed Mark Daly as the Chairman of its Scientific Advisory Board (SAB) and expanded its senior management team who will be located at its new US headquarters in Cambridge, Massachusetts, USA
    Full story
  • NCBI Plans Genomics Hackathon

    Nov 16, 2015, 15:00 PM by Michael Croft
    NCBI News | In early January, NCBI will host a genomics hackathon with teams taking on network analysis of variants, structural variation, RNA-seq, streaming data and metadata, and more.
    Full story
  • Patients Reluctant to Share Health Data with Tech Companies

    Nov 16, 2015, 14:49 PM by Michael Croft
    MIT Technology Review | A survey finds that consumers are wary of giving their personal health information to insurers, pharma companies, government, and especially tech companies like Google, Apple and Facebook.
    Full story